.parallax-bg { background-color: rgba(0, 0, 0, 0.5)!important; }


Innovative Suppositories Production

Suppositories offer the best form of dosage for various vaginal and rectal applications. The suppositories dosage rapidly absorbs through the vaginal or colonic membranes of mucosal. Plus, the API does not expose to hepatic or digestive system metabolism. Different mixtures can make suppositories. The formulation of suppositories is solid, but it rapidly melts when it enters the body.

At LGM Pharma, we manufacture high-quality suppositories under strict quality control and sanitized conditions. Our experts are knowledgeable and experienced in using state-of-the-art technology and techniques for suppositories manufacturing and production.

We have the capability to produce suppositories doses of 0.5 gram to 3.0 gram and a production capacity of 35,000,000 doses. Moreover, we ensure to maintain the consistency of formulation throughout the production process. Our experienced professionals provide regulatory guidance to ensure compliance with cGMP standards and regulations.

Highlight Features of Our Suppositories Production (Rosenberg, TX)

  • Production capabilities: Suppositories
  • Our production capacity:35,000,000 doses 0.5 gram – 3.0 gram
  • Types of equipment we use for suppositories production: Form, Fill, Seal, and Carton
  • Batch sizes: 50 –1,800 kg
  • Available suppositories packaging options: PVC/PE Film, In-House Film Printing, Multiple Packaging Configurations to Meet Customer Needs
  • Track and trace: Estimated Launch Date –12/2021

In our CDMO division, our trained and certified experts perform quality assurance at each step of the production process of each batch and before sending it for distribution. Plus, we ensure every suppositories batch complies with international quality standards and regulations. Using our expertise, we ensure that your batch formulation and dosage remain precisely the same as your requirements.

Contact us now to explore how our suppositories production can help you introduce your dosage form in the market quickly and efficiently

LGM Pharma Acquires CDMO

On July 27, 2020, LGM Pharma announced its acquisition of the formulation development and drug product contract manufacturing business of Nexgen Pharma, Inc. As a result, you will notice our new logo and visuals throughout the website. We’re working on updates to reflect the exciting, expanded CDMO capabilities and services we now can offer you.

This website uses cookies. By using our site, you agree to our terms of service